{
    "Trade/Device Name(s)": [
        "HemosIL Chromogenic Factor IX"
    ],
    "Submitter Information": "Instrumentation Laboratory Company",
    "510(k) Number": "K230852",
    "Predicate Device Reference 510(k) Number(s)": [
        "K031829"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "GGP"
    ],
    "Summary Letter Date": "March 27, 2023",
    "Summary Letter Received Date": "March 28, 2023",
    "Submission Date": "December 12, 2023",
    "Regulation Number(s)": [
        "21 CFR 864.7290"
    ],
    "Regulation Name(s)": [
        "Factor deficiency test"
    ],
    "Analyte Class(es)": [
        "coagulation",
        "hematology"
    ],
    "Analyte(s)": [
        "Factor IX"
    ],
    "Specimen Type(s)": [
        "3.2% citrated plasma"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "ACL TOP Family",
        "ACL TOP Family 50 Series"
    ],
    "Method(s)/Technology(ies)": [
        "Chromogenic assay",
        "Photometric quantitative determination"
    ],
    "Methodologies": [
        "Chromogenic factor IX activity determination"
    ],
    "Submission Type(s)": [
        "Assay",
        "Reagent",
        "Kit"
    ],
    "Document Summary": "FDA 510(k) summary for HemosIL Chromogenic Factor IX automated assay for photometric quantitative determination of factor IX activity using chromogenic technology on ACL TOP Family platforms.",
    "Indications for Use Summary": "Automated assay for photometric, quantitative determination of factor IX activity in 3.2% citrated plasma to identify factor IX deficiency or measure activity from patients on replacement therapy; for adult population only, prescription use.",
    "fda_folder": "Hematology"
}